Cutaneous pleomorphic fibromas arising in patients with germline TP53 mutations

被引:9
|
作者
Cloutier, Jeffrey M. [1 ]
Shalin, Sara C. [2 ,3 ]
Lindberg, Matthew [2 ,3 ]
Gardner, Jerad M. [2 ,3 ]
Fernandez-Pol, Sebastian [1 ]
Zaba, Lisa [4 ]
Novoa, Roberto [1 ,4 ]
Brown, Ryanne A. [1 ,4 ]
机构
[1] Stanford Univ, Dept Pathol, Sch Med, 3375 Hillview Ave,Room 1810, Stanford, CA 94304 USA
[2] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Dermatol, Little Rock, AR 72205 USA
[4] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94304 USA
关键词
Li-Fraumeni syndrome; p53; pleomorphic fibroma; Rb; FRAUMENI; INSTABILITY; P53;
D O I
10.1111/cup.13686
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Pleomorphic fibromas are rare benign cutaneous neoplasms associated with deletion/loss of chromosomes 13q and 17p, where RB1 and TP53 are located, respectively. Herein, we report five cases of pleomorphic fibroma arising in patients with germline TP53 mutations, suggesting a potential link with Li-Fraumeni syndrome. All three patients were female and young (mean age 27) with a strong personal and/or family oncologic history and confirmed pathogenic germline TP53 mutations. In two patients, multiple pleomorphic fibromas were diagnosed. Clinically, the lesions arose at various cutaneous sites and were small (<= 2 cm) and raised (4/5). Histopathologically, the tumors were paucicellular, composed of atypical spindled to stellate cells with hyperchromatic and variably pleomorphic nuclei. Mitotic activity was exceedingly low, although rare atypical mitotic figures were seen in one case. Immunohistochemically, the tumor cells were diffusely positive for p16 (3/3) and showed loss of Rb expression (5/5). All cases showed aberrant p53 expression (overexpression in 4, complete loss in 1). The tumors have followed a benign clinical course with no evidence of progression or recurrence. In conclusion, the development of multiple pleomorphic fibromas in a young patient may be a clue to an underlying genetic cancer syndrome involving TP53.
引用
收藏
页码:734 / 741
页数:8
相关论文
共 50 条
  • [1] Surveillance recommendations for patients with germline TP53 mutations
    Ballinger, Mandy L.
    Mitchell, Gillian
    Thomas, David M.
    [J]. CURRENT OPINION IN ONCOLOGY, 2015, 27 (04) : 332 - 337
  • [2] Germline mutations in the TP53 gene
    Eeles, RA
    [J]. CANCER SURVEYS, 1995, 25 : 101 - 124
  • [3] TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma
    Herrmann, Leonie J. M.
    Heinze, Britta
    Fassnacht, Martin
    Willenberg, Holger S.
    Quinkler, Marcus
    Reisch, Nicole
    Zink, Martina
    Allolio, Bruno
    Hahner, Stefanie
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (03): : E476 - E485
  • [4] Three germline mutations in the TP53 gene
    Cornelis, RS
    vanVliet, M
    vandeVijver, MJ
    Vasen, HFA
    Voute, PA
    Top, B
    Khan, PM
    Devilee, P
    Cornelisse, CJ
    [J]. HUMAN MUTATION, 1997, 9 (02) : 157 - 163
  • [5] Drastic Effect of Germline TP53 Missense Mutations in LiFraumeni Patients
    Zerdoumi, Yasmine
    Aury-Landas, Juliette
    Bonaiti-Pellie, Catherine
    Derambure, Celine
    Sesbouee, Richard
    Renaux-Petel, Mariette
    Frebourg, Thierry
    Bougeard, Gaelle
    Flaman, Jean-Michel
    [J]. HUMAN MUTATION, 2013, 34 (03) : 453 - 461
  • [6] Genotype and phenotype in carriers of germline TP53 mutations
    Varley, J
    Evans, DGR
    Kelsey, AM
    Birch, JM
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 : S22 - S22
  • [7] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    [J]. TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [8] Genotype and phenotype in carriers of germline tp53 mutations
    Varley J.
    Evans G.
    Birch J.
    Kelsey A.
    [J]. Nature Genetics, 2001, 27 (Suppl 4) : 92 - 93
  • [9] Germline TP53 mutations and Li-Fraumeni syndrome
    Varley, JM
    [J]. HUMAN MUTATION, 2003, 21 (03) : 313 - 320
  • [10] Loss of heterozygosity in tumours of carriers of germline TP53 mutations
    Goetz, P
    Trkova, M
    Foretova, L
    Krutilkova, V
    Kodet, R
    Mares, J
    Sedlacek, Z
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 89 - 89